We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $8.34B
1-Year Est. Return 46.58%
This Fund
S&P 500
This Quarter Est. Return
+5.42%
1 Year Est. Return
+46.58%
3 Year Est. Return
+191.6%
5 Year Est. Return
+200.35%
10 Year Est. Return
+3,561.44%
AUM
$7.98B
AUM Growth
-$21.8M
Cap. Flow
-$149M
Cap. Flow %
-1.86%
Top 10 Hldgs %
34.31%
Holding
287
New
30
Increased
70
Reduced
150
Closed
36

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$82.6M
2
EMBJ
Embraer S.A. ADS
EMBJ
+$56.2M
3
TBBB icon
BBB Foods
TBBB
+$39.9M
4
NTRA icon
Natera
NTRA
+$35.9M
5
LOAR icon
Loar Holdings
LOAR
+$29.9M

Top Sells

Rank Stock Value
1
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$171M
2
NVDA icon
NVIDIA
NVDA
+$107M
3
INTC icon
Intel
INTC
+$54.3M
4
DNLI icon
Denali Therapeutics
DNLI
+$24.1M
5
NFLX icon
Netflix
NFLX
+$20.2M

Sector Composition

Rank Sector Weight
1 Technology 31.65%
2 Consumer Discretionary 19.21%
3 Healthcare 16.85%
4 Communication Services 13.51%
5 Industrials 6.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IVVD icon
251
Invivyd
IVVD
$169M
$19.8K ﹤0.01%
17,971
-1,231,140
-99% -$2.72M
ADPT icon
252
Adaptive Biotechnologies
ADPT
$3.9B
– –
-1,245,111
Closed -$4M
BE icon
253
Bloom Energy
BE
$67.2B
– –
-19,588
Closed -$220K
BHVN icon
254
Biohaven
BHVN
$2.07B
– –
-20,673
Closed -$1.13M
CAE icon
255
CAE Inc. Common Shares
CAE
$8.62B
– –
-594,254
Closed -$12.3M
CFLT
256
DELISTED
Confluent
CFLT
– –
-137,100
Closed -$4.18M
CGON icon
257
CG Oncology
CGON
$6.3B
– –
-18,523
Closed -$813K
COHR icon
258
Coherent
COHR
$63.3B
– –
-15,656
Closed -$949K
DNLI icon
259
Denali Therapeutics
DNLI
$3.84B
– –
-1,172,785
Closed -$24.1M
EVRI
260
DELISTED
Everi Holdings
EVRI
– –
-84,429
Closed -$849K
FRSH icon
261
Freshworks
FRSH
$3.33B
– –
-282,621
Closed -$5.15M
FULC icon
262
Fulcrum Therapeutics
FULC
$290M
– –
-65,600
Closed -$619K
HRI icon
263
Herc Holdings
HRI
$5.71B
– –
-26,150
Closed -$4.4M
LULU icon
264
lululemon athletica
LULU
$14B
– –
-36,600
Closed -$14.3M
MDT icon
265
Medtronic
MDT
$110B
– –
-22,487
Closed -$1.96M
ODD icon
266
ODDITY Tech
ODD
$706M
– –
-16,830
Closed -$731K
PANW icon
267
Palo Alto Networks
PANW
$299B
– –
-131,262
Closed -$18.6M
PATH icon
268
UiPath
PATH
$7.31B
– –
-24,890
Closed -$564K
PENN icon
269
PENN Entertainment
PENN
$2.68B
– –
-13,294
Closed -$242K
RCKT icon
270
Rocket Pharmaceuticals
RCKT
$376M
– –
-19,270
Closed -$519K
SANA icon
271
Sana Biotechnology
SANA
$946M
– –
-84,259
Closed -$843K
SBUX icon
272
Starbucks
SBUX
$120B
– –
-99,887
Closed -$9.13M
SHLS icon
273
Shoals Technologies Group
SHLS
$1.55B
– –
-19,910
Closed -$223K
SPT icon
274
Sprout Social
SPT
$526M
– –
-159,410
Closed -$9.52M
TDW icon
275
Tidewater
TDW
$4.19B
– –
-3,328
Closed -$306K
8 9 10
11
12

Similar funds

AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
LGF
LGT Group Foundation Vaduz, Liechtenstein $8.19B AUM 27.7% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return

Gilder Gagnon Howe & Co's Q2 2024 Portfolio in Review

As of Q2 2024, Gilder Gagnon Howe & Co held 287 positions worth $7.98B, down 0.27% from $8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Gilder Gagnon Howe & Co's Q2 2024 filing shows 30 new, 70 increased, 150 reduced and 36 closed positions. Its largest new stake was Boston Scientific: 1,128,740 shares worth $86.9M. The largest sale was Shockwave Medical, Inc. Common Stock, an estimated $171M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Gilder Gagnon Howe & Co's largest Q2 2024 buy was Boston Scientific: 1,128,740 shares worth $86.9M.
  • Gilder Gagnon Howe & Co added most to BBB Foods in Q2 2024, an estimated $39.9M increase.
  • Gilder Gagnon Howe & Co's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $107M.
  • Gilder Gagnon Howe & Co fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $171M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 34% of its $7.98B portfolio in Q2 2024.
  • Gilder Gagnon Howe & Co opened 30 new positions and closed 36 in Q2 2024.
  • Gilder Gagnon Howe & Co's portfolio value fell 0.27% quarter-over-quarter to $7.98B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2024, filed 14 Aug 2024.